Hutchmed [China] Limited (HCM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 3,605 | 780 | -19,174 | 6,904 | -1,111 |
| Accounts receivable | -41,573 | -13,051 | -2,379 | -41,392 | -14,295 |
| Other Working Capital | -62,169 | 71,146 | 58,704 | 32,458 | 29,273 |
| Other Operating Activity | 100,634 | 160,383 | -305,750 | -202,193 | -75,933 |
| Operating Cash Flow | $497 | $219,258 | $-268,599 | $-204,223 | $-62,066 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,655 | -32,612 | -36,664 | -15,826 | -19,580 |
| Net Acquisitions | 0 | -2,990 | 324 | 159,118 | 0 |
| Purchase Of Investment | -1,848,808 | -1,627,875 | -1,202,013 | -1,370,976 | -732,908 |
| Sale Of Investment | 1,769,403 | 1,342,846 | 1,518,453 | 921,364 | 629,373 |
| Other Investing Activity | 0 | 29,495 | 16,488 | 0 | -2,326 |
| Investing Cash Flow | $-96,060 | $-291,136 | $296,588 | $-306,320 | $-125,441 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 36,199 | 61,705 | 17,753 | N/A | 0 |
| Debt Repayment | -30,592 | 0 | -26,923 | N/A | 0 |
| Common Stock Issued | 790 | 5,094 | 174 | 717,319 | 318,934 |
| Common Stock Repurchased | -36,064 | -9,071 | -48,084 | -27,309 | -12,904 |
| Other Financing Activity | -1,000 | -9,068 | -25,683 | -39,982 | -9,596 |
| Financing Cash Flow | $-30,667 | $48,660 | $-82,763 | $650,028 | $296,434 |
| Exchange Rate Effect | -3,401 | -6,471 | -9,490 | 2,427 | 5,546 |
| Beginning Cash Position | 283,589 | 313,278 | 377,542 | 235,630 | 121,157 |
| End Cash Position | 153,958 | 283,589 | 313,278 | 377,542 | 235,630 |
| Net Cash Flow | $-126,230 | $-23,218 | $-54,774 | $139,485 | $108,927 |
| Free Cash Flow | |||||
| Operating Cash Flow | 497 | 219,258 | -268,599 | -204,223 | -62,066 |
| Capital Expenditure | -17,933 | -32,612 | -36,664 | -16,756 | -19,580 |
| Free Cash Flow | -17,436 | 186,646 | -305,263 | -220,979 | -81,646 |